Results 1 to 10 of about 487,201 (201)

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

open access: yesNew England Journal of Medicine, 2004
BACKGROUND: The use of aspirin for the prevention of thrombotic complications in polycythemia vera is controversial. METHODS: We enrolled 518 patients with polycythemia vera, no clear indication for aspirin treatment, and no contraindication to such ...
Roberto Marchioli   +2 more
exaly   +2 more sources

Ruxolitinib Versus Standard Therapy for the Treatment of Polycythemia Vera [PDF]

open access: yesNew England Journal of Medicine, 2015
BACKGROUND Ruxolitinib, a Janus kinase (JAK) 1 and 2 inhibitor, was shown to have a clinical benefit in patients with polycythemia vera in a phase 2 study.
Alessandro Maria Vannucchi   +2 more
exaly   +4 more sources
Some of the next articles are maybe not open access.

Bone-Marrow Responses in Polycythemia Vera

New England Journal of Medicine, 1974
A A Axelrad, J F Prchal
exaly  

PSYCHOSIS IN POLYCYTHEMIA VERA

The Journal of Nervous and Mental Disease, 1952
openaire   +2 more sources

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

New England Journal of Medicine, 2013
Elena Maria Elli   +2 more
exaly  

Surgical Implications of Polycythemia Vera °

Annals of Surgery, 1960
W T, FITTS   +3 more
openaire   +2 more sources

Polycythemia Vera: Stem-Cell and Probable Clonal Origin of the Disease

New England Journal of Medicine, 1976
L Steinmann   +2 more
exaly  

Increased Incidence of Acute Leukemia in Polycythemia Vera Associated With Chlorambucil Therapy

New England Journal of Medicine, 1981
Murray N Silverstein   +2 more
exaly  

Current Management Strategies for Polycythemia Vera and Essential Thrombocythemia

Blood Reviews, 2020
Alessandro Maria Vannucchi   +1 more
exaly  

Home - About - Disclaimer - Privacy